International
The Morning Science

What science found today

‹
 

Research

Lysine- R 2HGylation-C5 identified as a post-translational modification in R 2HG-elevated cancers

Nature · By Qian Zhao ·

The Brief

  • R-2-hydroxyglutarate is a cancer-linked metabolite whose mechanisms are incompletely understood.
  • The authors identify lysine R2HGylation as a protein post-translational modification and structurally characterize it.
  • The findings are reported in a Nature Communications paper published online on 18 November 2026.

Why it matters

A previously unrecognized protein modification linked to a cancer-associated metabolite could help explain how R-2-hydroxyglutarate affects cancer cells, which may inform future research on these tumours.

Who’s affected

  • cancer biologists
  • metabolism researchers

Nature Communications, Published online: 18 November 2026; doi:10.1038/s41467-026-79668-2 R-2-hydroxyglutarate is a cancer-linked metabolite whose mechanisms are incompletely understood. Here, the authors identify and structurally characterize lysineR2HGylation as a protein…

Timeline

  1. Published online in Nature Communications

  2. nature.com

    Lysine- R 2HGylation-C5 identified as a post-translational modification in R 2HG-elevated cancers

How do you feel about this?

0 Comments

    Lysine- R 2HGylation-C5 identified as a post-translational modification in R 2HG-elevated cancers – The Morning Science